Regencell Bioscience Holdings Limited (RGC)Healthcare | Drug Manufacturers - Specialty & Generic | Causeway Bay, Hong Kong | NasdaqCM
28.67 USD
-1.90
(-6.215%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 28.71 +0.04 (0.140%) ⇧ (April 17, 2026, 7:44 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 1:17 p.m. EDT
Regencell Bioscience shows a mixed picture with short-term bearish options flow and volatile price action, suggesting caution for short-term investors. Long-term fundamentals are weak with negative earnings and high debt, making it a risky long-term hold. No dividend payouts indicate no income generation potential. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.106155 |
| AutoETS | 0.119495 |
| AutoTheta | 0.233662 |
| AutoARIMA | 0.296132 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 85% |
| H-stat | 0.77 |
| Ljung-Box p | 0.013 |
| Jarque-Bera p | 0.334 |
| Excess Kurtosis | -0.61 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 11.201 |
| Market Cap | 14,176,996,352 |
| Beta | 2.25 |
| Website | https://www.regencellbioscience.com |
As of April 18, 2026, 1:17 p.m. EDT: Options speculators are showing mixed sentiment. Puts are heavily weighted, especially around the ATM strike of $30.00, indicating potential bearish bias. However, calls are also showing activity, particularly in the $35.00 and $40.00 strikes, suggesting some bullish positioning. The high IV on puts and the presence of significant OI in out-of-the-money puts suggest caution or short-term bearish expectations. The recent price action has been volatile, with a recent drop to $28.67, which could be a catalyst for further short-term downside.
| Attribute | Value |
|---|---|
| 52 Week Change | 36.56758 |
| Address1 | Chinachem Leighton Plaza |
| Address2 | 9th Floor 29 Leighton Road |
| All Time High | 83.6 |
| All Time Low | 0.079737 |
| Ask | 36.19 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 112,210 |
| Average Daily Volume3 Month | 211,961 |
| Average Volume | 211,961 |
| Average Volume10Days | 112,210 |
| Beta | 2.247 |
| Bid | 21.96 |
| Bid Size | 2 |
| Book Value | 0.01 |
| City | Causeway Bay |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Hong Kong |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 28.67 |
| Current Ratio | 7.387 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 30.5 |
| Day Low | 28.08 |
| Debt To Equity | 11.201 |
| Earnings Timestamp End | 1,780,430,400 |
| Earnings Timestamp Start | 1,780,430,400 |
| Ebitda | -3,692,293 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -3,838.44 |
| Enterprise Value | 14,172,644,352 |
| Eps Trailing Twelve Months | -0.01 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 852 2155 0853 |
| Fifty Day Average | 27.1311 |
| Fifty Day Average Change | 1.5389004 |
| Fifty Day Average Change Percent | 0.056720898 |
| Fifty Two Week Change Percent | 3,656.758 |
| Fifty Two Week High | 83.6 |
| Fifty Two Week High Change | -54.93 |
| Fifty Two Week High Change Percent | -0.6570574 |
| Fifty Two Week Low | 0.703237 |
| Fifty Two Week Low Change | 27.966763 |
| Fifty Two Week Low Change Percent | 39.768616 |
| Fifty Two Week Range | 0.703237 - 83.6 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,626,442,200,000 |
| Float Shares | 43,940,284 |
| Free Cashflow | -1,507,277 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 10 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.88555 |
| Held Percent Institutions | 0.00118 |
| Implied Shares Outstanding | 494,488,909 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Ipo Expected Date | 2,021-07-16 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,751,241,600 |
| Last Split Date | 1,750,032,000 |
| Last Split Factor | 38:1 |
| Long Business Summary | Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong. |
| Long Name | Regencell Bioscience Holdings Limited |
| Market | us_market |
| Market Cap | 14,176,996,352 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_695870118 |
| Most Recent Quarter | 1,751,241,600 |
| Net Income To Common | -3,584,213 |
| Next Fiscal Year End | 1,782,777,600 |
| Non Diluted Market Cap | 14,176,996,992 |
| Open | 30.46 |
| Operating Cashflow | -3,113,576 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 852 2155 0823 |
| Post Market Change | 0.03999901 |
| Post Market Change Percent | 0.1395152 |
| Post Market Price | 28.71 |
| Post Market Time | 1,776,469,488 |
| Previous Close | 30.57 |
| Price Hint | 2 |
| Price To Book | 2,867.0 |
| Profit Margins | 0.0 |
| Quick Ratio | 7.379 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -1.9 |
| Regular Market Change Percent | -6.21524 |
| Regular Market Day High | 30.5 |
| Regular Market Day Low | 28.08 |
| Regular Market Day Range | 28.08 - 30.5 |
| Regular Market Open | 30.46 |
| Regular Market Previous Close | 30.57 |
| Regular Market Price | 28.67 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 151,689 |
| Return On Assets | -0.33201 |
| Return On Equity | -0.54809 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 494,488,908 |
| Shares Percent Shares Out | 0.0014 |
| Shares Short | 700,509 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 634,850 |
| Short Name | Regencell Bioscience Holdings L |
| Short Percent Of Float | 0.0126 |
| Short Ratio | 5.62 |
| Source Interval | 15 |
| Symbol | RGC |
| Total Cash | 4,897,015 |
| Total Cash Per Share | 0.01 |
| Total Debt | 544,415 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.01 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 20.15275 |
| Two Hundred Day Average Change | 8.51725 |
| Two Hundred Day Average Change Percent | 0.42263463 |
| Type Disp | Equity |
| Volume | 151,689 |
| Website | https://www.regencellbioscience.com |